Hsbc Holdings »

Vor Biopharma shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $51k 49k 1.04
2024-03-31 $42k 18k 2.37

More positions owned by Hsbc Holdings

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Hsbc Holdings

Top funds holding Vor Biopharma

RA Capital Management
5AM Venture Management
Hudson Bay Capital Management
Vanguard Group
Cowen And Company
Johnson & Johnson
Renaissance Technologies
Sarissa Capital Management
BlackRock
BlackRock
MAI Wealth Advisors
Geode Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Morgan Stanley

View all funds holding Vor Biopharma